Medical specialists from Australia tagged as investigators in clinical trials studying Leukemia
Total 81 results
-
Allison BarracloughSeen in:
- Murdoch, Fiona Stanley Hospital
- Western Australia, Murdoch, Fiona Stanley Hospital
Trials:- NCT04332822 (Principal Investigator)
- NCT04965493 (Principal Investigator)
-
Andrew S. MooreSeen in:
- Queensland, South Brisbane, Queensland Children's Hospital
Trials:- NCT04726241 (Principal Investigator)
Conditions: -
Andrew WeiSeen in:
- Melbourne, AU-Melbourne-ALFRED
Trials:- NCT04027309 (Principal Investigator)
-
Anish PuliyayilSeen in:
- Albury, Border Medical Oncology Research Unit
- New South Wales, Albury, Border Medical Oncology
Trials:- NCT04332822 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT03850574 (Principal Investigator)
-
Anna JohnstonSeen in:
- Hobart, Royal Hobart Hospital
- South Australia, Adelaide, Royal Adelaide Hospital
- Tasmania, Hobart, Royal Hobart Hospital
Trials:- NCT04332822 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Anoop K EnjetiSeen in:
- New South Wales, Newcastle, Calvary Mater
Trials:- NCT05456269 (Principal Investigator)
-
Anthony P Schwarer, MB, BS, FRACP, MD, FRCPASeen in:
- Victoria, Melbourne, The Alfred Hosptial
Trials:- NCT00451711 (Principal Investigator)
Conditions: -
Anthony P. Schwarer, MB, BS, FRACP, MD, FRCPASeen in:
- Victoria, Melbourne, Box Hill Hospital, Eastern Health
Trials:- NCT00451711 (Principal Investigator)
Conditions: -
Anthony SchwarerSeen in:
- Victoria, Box Hill, Box Hill Hospital
Trials:- NCT03589326 (Principal Investigator)
-
Ashish BajelSeen in:
- Melbourne, AU-Melbourne-RMELBOURNE
- Victoria, Parkville, Royal Melbourne Hospital (RMH)
Trials:- NCT04027309 (Principal Investigator)
- NCT04065399 (Principal Investigator)
-
Bhavna PadhyeSeen in:
- New South Wales, Hunter Regional Mail Centre, John Hunter Children's Hospital
- New South Wales, Randwick, Sydney Children's Hospital
- New South Wales, Westmead, The Children's Hospital at Westmead
Trials:- NCT04759586 (Principal Investigator)
- NCT04238819 (Principal Investigator)
- NCT05457556 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT00772200 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Relapsed Solid Tumor;
- Refractory Solid Tumor;
- Acute Myeloid Leukemia;
- Acute Lymphoblastic Leukemia;
- Myelodysplastic Syndrome;
- Mixed Phenotype Acute Leukemia;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- T Acute Lymphoblastic Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Juvenile Myelomonocytic Leukemia;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Childhood Malignant Neoplasm
-
C. Orla Morrissey, MB, BCh, FRACPSeen in:
- Victoria, Melbourne, The Alfred Hosptial
Trials:- NCT00451711 (Principal Investigator)
Conditions: -
Carolyn GroveSeen in:
- Nedlands, Sir Charles Gairdner Hospital
- Perth, AU-Perth-SCGH
- Western Australia, Nedlands, Sir Charles Gairdner Hospital
Trials:- NCT04027309 (Principal Investigator)
- NCT04065399 (Principal Investigator)
- NCT03850574 (Principal Investigator)
-
Chong C Chua, MDSeen in:
- Victoria, Epping, The Northern Hospital
Trials:- NCT04964518 (Principal Investigator)
Conditions: -
Christain Bryant, MBSS PhDSeen in:
- New South Wales, Camperdown, Institute of Haematology, Royal Prince Alfred Hospital
Trials:- NCT05020678 (Principal Investigator)
-
Christopher FraserSeen in:
- Queensland, South Brisbane, Queensland Childrens Hospital
Trials:- NCT04501614 (Principal Investigator)
-
Christopher J. FraserSeen in:
- Queensland, South Brisbane, Queensland Children's Hospital
Trials:- NCT05286801 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT05359237 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03959085 (Principal Investigator)
Conditions:- Malignant Solid Neoplasm;
- Rhabdoid Tumor;
- Refractory Malignant Solid Neoplasm;
- Recurrent Malignant Solid Neoplasm;
- Recurrent Rhabdoid Tumor;
- Refractory Rhabdoid Tumor;
- Epithelioid Sarcoma;
- Kidney Medullary Carcinoma;
- Atypical Teratoid/Rhabdoid Tumor;
- Poorly Differentiated Chordoma;
- Recurrent Atypical Teratoid/Rhabdoid Tumor;
- Recurrent Chordoma;
- Recurrent Epithelioid Sarcoma;
- Recurrent Kidney Medullary Carcinoma;
- Refractory Atypical Teratoid/Rhabdoid Tumor;
- Refractory Chordoma;
- Refractory Epithelioid Sarcoma;
- Refractory Kidney Medullary Carcinoma;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Hematopoietic and Lymphoid Cell Neoplasm;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Central Nervous System Leukemia;
- Testicular Leukemia
-
Chun FongSeen in:
- Melbourne, AU-Melbourne-AUSTIN
Trials:- NCT04027309 (Principal Investigator)
-
Constantine TamSeen in:
- Victoria, Melbourne, The Alfred Hospital
Trials:- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Currently UnkownSeen in:
- Melbourne, AU-Melbourne-BOXHILL
Trials:- NCT04027309 (Principal Investigator)
-
David HughesSeen in:
- Victoria, Parkville, Royal Children's Hospital Melbourne - PIN
Trials:- NCT04501614 (Principal Investigator)
-
David Ritchie, MBBS, PhDSeen in:
- Victoria, Melbourne, Melbourne Health
Trials:- NCT05005299 (Principal Investigator)
-
David Ziegler, MDSeen in:
- New South Wales, Randwick, Sydney Children's Hospital
- New South Wales, Sydney, Kids Cancer Centre
- New South Wales, Sydney, Sydney Children's Hospital, Kids Cancer Center
Trials:- NCT05500508 (Principal Investigator)
- NCT04773782 (Principal Investigator)
- NCT02879643 (Principal Investigator)
Conditions:- Melanoma;
- Cervical Cancer;
- Cancer;
- Breast Cancer;
- Head and Neck Cancer;
- Gastric Cancer;
- Colorectal Cancer;
- Esophageal Cancer;
- Solid Tumor;
- Endometrial Cancer;
- Advanced Cancer;
- Diffuse Midline Glioma, H3 K27M-Mutant;
- Papillary Thyroid Cancer;
- Solid Carcinoma;
- Mesotheliomas Pleural;
- Glioma, Malignant;
- Ovary Cancer;
- DIPG Brain Tumor;
- Nsclc;
- Mesothelioma Peritoneum;
- CNS Tumor;
- Solid Tumor, Unspecified, Child;
- Relapsed Solid Neoplasm;
- Lymphoblastic Leukemia, Acute, Childhood;
- ALL, Childhood;
- Lymphoblastic Leukemia, Acute
-
Derek McCullochSeen in:
- Camperdown, AU-Camperdown-RPA
Trials:- NCT04027309 (Principal Investigator)
-
Diane HannaSeen in:
- Victoria, Parkville, Royal Children's Hospital
Trials:- NCT04759586 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03817398 (Principal Investigator)
-
Douglas Lenton, DMSeen in:
- New South Wales, Dubbo, Western NSW Local Health District
Trials:- NCT03412292 (Principal Investigator)
Conditions: -
Draga BarbaricSeen in:
- New South Wales, Randwick, Sydney Children's Hospital
Trials:- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT02176967 (Principal Investigator)
Conditions:- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Acute Lymphoblastic Leukemia;
- B Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Neuroblastoma;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Ganglioneuroblastoma
-
Duncan PurtillSeen in:
- Perth, AU-Perth-FSH
Trials:- NCT04027309 (Principal Investigator)
Clinical Trials on Leukemia
-
Massachusetts General HospitalCelgene CorporationTerminatedAcute Myelogenous Leukemia | Acute Myeloid Leukemia (AML) | Acute Myelocytic Leukemia | Acute Granulocytic Leukemia | Acute Non-Lymphocytic LeukemiaUnited States
-
Stanford UniversityTerminatedLeukemia | Leukemia, Lymphocytic, Acute | Leukemia Acute Promyelocytic Leukemia (APL) | Leukemia Acute Lymphoid Leukemia (ALL) | Leukemia Chronic Myelogenous Leukemia (CML) | Leukemia Acute Myeloid Leukemia (AML) | Leukemia Chronic Lymphocytic Leukemia (CLL)United States
-
Institute of Hematology & Blood Diseases HospitalBejing Institute for Stem Cell and Regenerative Medicine; Institute for Stem...RecruitingRefractory Leukemia | Relapsed Leukemia | Acute Myeloid Leukemia, ChildhoodChina
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Maturation | Adult Acute Myeloid Leukemia Without Maturation | Adult Acute Myelomonocytic Leukemia | Alkylating Agent-Related Acute Myeloid... and other conditionsUnited States
-
Hoffmann-La RocheCompletedNeoplasms, Myelogenous Leukemia, AcuteUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous LeukemiaJapan
-
Betta Pharmaceuticals Co., Ltd.Not yet recruitingAcute Myeloid Leukemia LeukemiaChina
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous Leukemia | Acute Promyelocytic LeukemiaUnited States
-
Massachusetts General HospitalCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia Without Maturation (M1) | Childhood Acute Myelomonocytic Leukemia (M4) | Childhood Acute Myeloid Leukemia/Other Myeloid MalignanciesUnited States